Home > Riviste > Minerva Biotecnologica > Fascicoli precedenti > Minerva Biotecnologica 2005 Settembre;17(3) > Minerva Biotecnologica 2005 Settembre;17(3):127-31

ULTIMO FASCICOLO
 

ARTICLE TOOLS

Estratti

MINERVA BIOTECNOLOGICA

Rivista di Biologia Molecolare e Biotecnologie


Indexed/Abstracted in: EMBASE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,246


eTOC

 

  MEDICINAL PLANTS FOR BIOTECHNOLOGY AND BIOMEDICINE


Minerva Biotecnologica 2005 Settembre;17(3):127-31

lingua: Inglese

The role of metabolic engineering for the production of secondary metabolites of plants

Khan M. T. H. 1, 2, Ather A. 2, Gambari R. 2, 3

1 Pharmacology Research Laboratory, Faculty of Pharmaceutical Sciences, University of Science and Technology, Chittagong, Bangladesh;
2 ER-GenTech, Department of Biochemistry and Molecular Biology, University of Ferrara, Ferrara, Italy;
3 Biotechnology Center, University of Ferrara, Ferrara, Italy


Full text temporaneamente non disponibile on-line. Contattaci  


Plants are very interesting and useful sources of molecules of great importance for the development of new pharmaceutical products. Metabolic engineering has proven to be a valuable tool for large production of several biomedically as well as industrially relevant compounds from micro-organisms as well from higher plants. Current development of studies employing transgenic and/or recombinant technologies have opened up opportunities of the metabolic engineering/ metabolo-mics of biosynthetic pathways, leading to the growth of manufacturing of high-value secondary metabolites, even at the commercial level.

inizio pagina

Publication History

Per citare questo articolo

Corresponding author e-mail